Abstract

Australia commenced its COVID-19 vaccine program for children aged 12–15 years from July 2021 and for children aged 5–11 years from January 2022 with two primary doses of either Comirnaty (Pfizer–BioNTech BNT162b2, 10 μg for 5–11 years and 30 μg for 12–15 years) or Spikevax (Moderna mRNA-1273, 50 μg for 6–11 years and 100 μg for 12–15 years), 8 weeks apart. A booster dose is recommended for those aged 5–15 years with complex health conditions or severe immunocompromise.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.